EUVIMEDEUVIMED entdecken
Open Access

Hospitalization Following Outpatient Diagnosis of Respiratory Syncytial Virus in Adults

Suzanne N Landi, Diana C Garofalo, Maya Reimbaeva, Amie M Scott, Lili Jiang, Katherine Cappell, David Lewandowski, Machaon Bonafede, Kaylen Brzozowski, Zuzanna Drebert, Mike Temple, Margaret Tawadrous und 6 weitere

JAMA Network Open · 19.11.2024 · 7 (11) · e2446010

DOI: 10.1001/jamanetworkopen.2024.46010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 19.11.2024. Verfasst von Suzanne N Landi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Inc, New York, New York. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Hospitalization. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Respiratory syncytial virus (RSV) is a leading cause of acute respiratory tract infections among adults and is estimated to cause approximately 159 000 hospitalizations among adults aged 65 years and older in the US each year. Estimates of hospitalization among adults with outpatient medically attended RSV (MA-RSV) infections are required to design interventional studies that aim to prevent hospitalization.

Objective

To assess absolute risk of 28-day, all-cause hospitalization following outpatient MA-RSV infections in adults. Design, Setting, and Participants In this cohort study, data from 3 different deidentified databases containing electronic health records (EHR) linked to closed claims data (Optum’s deidentified Integrated Claims-Clinical dataset, TriNetX Linked, and Veradigm Network EHR [VNEHR] database linked with claims) were analyzed separately across 6 RSV years (October 1, 2016, to September 30, 2022) in adults with commercial or government insurance. Outpatient (eg, clinics and emergency departments) MA-RSV infections were identified based on clinical laboratory data or RSV-specific International Statistical Classification of Diseases, Tenth Revision, Clinical Modification ( ICD-10-CM ) diagnosis codes. Data were analyzed from March 2023 to April 2024. Main Outcomes and Measures The main outcome was all-cause 28-day hospitalization following outpatient MA-RSV infections among all adults and a high-risk subgroup (defined as age ≥65 years or with asthma, chronic obstructive pulmonary disease [COPD], or congestive heart failure [CHF]).

Results

In this cohort study of 67 239 MA-RSV infections in adults (2771 from Optum, 7442 from TriNetX, and 57 026 from VNEHR), most occurred among females (62%-67%) and comorbidity prevalences were 20.0% to 30.5% for COPD, 14.6% to 24.4% for CHF, 14.6% to 24.4% for asthma; 14.0% to 54.5% of individuals were aged 65 years or older. The proportion hospitalized was 6.2% (95% CI, 5.3%-7.1%) in Optum, 6.0% (95% CI, 5.4% to 6.5%) in TriNetX, and 4.5% (95% CI, 4.3%-4.6%) in VNEHR. Among the high-risk subgroup, the proportion hospitalized was 7.6% (95% CI, 6.5%-8.9%) in Optum, 8.5% (95% CI, 7.6%-9.4%) in TriNetX, and 6.5% (95% CI, 6.2%-6.8%) in VNEHR. Conclusions and Relevance In this cohort study of adults with outpatient MA-RSV infections from 3 large deidentified US databases across 6 RSV seasons, approximately 1 in 20 adults experienced all-cause hospitalization within 28 days. The results of this study highlight the public health need for RSV prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsHospitalizationHumansFemaleMaleAgedMiddle AgedAdultCohort StudiesUnited StatesOutpatientsDatabases, FactualAmbulatory Care

Autor:innen und Institutionen

  • Pfizer Inc, New York, New York.
  • Pfizer Inc, Groton, Connecticut.
  • Veradigm Inc, Chicago, Illinois.
  • TriNetX, Cambridge, Massachusetts.
  • Pfizer Inc, Cambridge, Massachusetts.
  • Pfizer Inc, Dublin, Ireland.

Zitieren

APA

Landi, S. N., Garofalo, D. C., Reimbaeva, M., Scott, A. M., Jiang, L., Cappell, K., Lewandowski, D., Bonafede, M., Brzozowski, K., Drebert, Z., Temple, M., Tawadrous, M., Pixton, G. C., Alami, N., Kelly, S. P., Aliabadi, N., Begier, E., & Swan, J. T. (2024). Hospitalization Following Outpatient Diagnosis of Respiratory Syncytial Virus in Adults. JAMA Network Open, 7(11), e2446010. https://doi.org/10.1001/jamanetworkopen.2024.46010

Vancouver

Landi SN, Garofalo DC, Reimbaeva M, Scott AM, Jiang L, Cappell K, et al. Hospitalization Following Outpatient Diagnosis of Respiratory Syncytial Virus in Adults. JAMA Network Open. 2024;7(11):e2446010. doi:10.1001/jamanetworkopen.2024.46010

BibTeX
@article{Landi2024,
  author = {Landi, Suzanne N and Garofalo, Diana C and Reimbaeva, Maya and Scott, Amie M and Jiang, Lili and Cappell, Katherine and Lewandowski, David and Bonafede, Machaon and Brzozowski, Kaylen and Drebert, Zuzanna and Temple, Mike and Tawadrous, Margaret and Pixton, Glenn C and Alami, Niki and Kelly, Scott P and Aliabadi, Negar and Begier, Elizabeth and Swan, Joshua T},
  title = {Hospitalization Following Outpatient Diagnosis of Respiratory Syncytial Virus in Adults},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {11},
  pages = {e2446010},
  doi = {10.1001/jamanetworkopen.2024.46010}
}
Kostenlos starten →